The membership of PPTA includes the collectors of source plasma and manufacturers of plasma-derived and recombinant analog therapies. Member companies are represented on the global and regional Board of Directors, the Global Management Committee and steering committees and taskforces.
Working cooperatively with consumer groups, policy makers and other key stakeholders, PPTA addresses critical issues that affect the industry and patients who rely on plasma protein therapies.
The Plasma Protein Therapeutics Association (PPTA) is an essential part of the plasma protein therapeutics industry, representing a broad spectrum of firms, large, multi-national companies and small businesses.
For information on how to become a member of PPTA, contact the Membership Services office of PPTA, by calling 202.789.3100 or by emailing email@example.com.
PPTA is Proud to Support Rare Disease Day 2017 +
The Plasma Protein Therapeutics Association (PPTA) is proud to support Rare Disease Day, an annual international event that seeks to raise awareness about rare diseases and the patients and families that are affected by a rare disease.Read More
PPTA Statement on the Documentary “Das Geschäft mit dem Blut” +
PPTA has viewed the documentary "Das Geschäft mit dem Blut" / "Le business du sang" (http://future.arte.tv/fr/le-business-du-sang) that will air on Feb. 21, 2017 in Germany, France, and Belgium on ARTE TV. PPTA strongly objects to the content of the documentary because it is not factual and contains numerous inaccuracies and misinformation.Read More
PPTA Remembers Corey Dubin +
The Plasma Protein Therapeutics Association (PPTA) notes with sadness the passing of Corey Dubin, President Emeritus of the Committee of Ten Thousand and longtime advocate in the hemophilia community.Read More